HIA
ABBV icon

Harbor Investment Advisory’s AbbVie ABBV Stock Holding History

Harbor Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03M Sell
19,981
-69
-0.3% -$14.8K 0.35% 60
2026
Q1 		$4.36M Sell
20,050
-2,042
-9% -$453K 0.34% 60
2025
Q4 		$5.05M Buy
22,092
+224
+1% +$51K 0.38% 48
2025
Q3 		$5.06M Sell
21,868
-21
-0.1% -$4.28K 0.42% 46
2025
Q2 		$4.06M Buy
21,889
+497
+2% +$92.4K 0.36% 56
2025
Q1 		$4.48M Sell
21,392
-400
-2% -$77.8K 0.44% 45
2024
Q4 		$3.87M Sell
21,792
-539
-2% -$99.1K 0.36% 54
2024
Q3 		$4.41M Sell
22,331
-547
-2% -$102K 0.43% 42
2024
Q2 		$3.92M Buy
22,878
+2,095
+10% +$347K 0.41% 46
2024
Q1 		$3.78M Buy
20,783
+141
+0.7% +$24.3K 0.4% 49
2023
Q4 		$3.2M Sell
20,642
-469
-2% -$68.4K 0.37% 55
2023
Q3 		$3.15M Sell
21,111
-1,713
-8% -$251K 0.41% 47
2023
Q2 		$3.08M Sell
22,824
-648
-3% -$95K 0.43% 54
2023
Q1 		$3.74M Buy
23,472
+3
+0% +$459 0.56% 37
2022
Q4 		$3.79M Buy
23,469
+1,225
+6% +$188K 0.59% 36
2022
Q3 		$2.98M Sell
22,244
-364
-2% -$52.2K 0.49% 43
2022
Q2 		$3.46M Sell
22,608
-1,175
-5% -$180K 0.55% 34
2022
Q1 		$3.86M Sell
23,783
-171
-0.7% -$24.8K 0.51% 37
2021
Q4 		$3.24M Sell
23,954
-246
-1% -$29.1K 0.41% 49
2021
Q3 		$2.61M Sell
24,200
-1,693
-7% -$193K 0.35% 58
2021
Q2 		$2.92M Buy
25,893
+760
+3% +$85.6K 0.4% 51
2021
Q1 		$2.72M Sell
25,133
-223
-0.9% -$23.9K 0.41% 56
2020
Q4 		$2.72M Buy
25,356
+96
+0.4% +$9.22K 0.44% 50
2020
Q3 		$2.21M Buy
25,260
+177
+0.7% +$16.7K 0.42% 56
2020
Q2 		$2.46M Buy
25,083
+445
+2% +$39.2K 0.52% 44
2020
Q1 		$1.88M Sell
24,638
-552
-2% -$47K 0.51% 50
2019
Q4 		$2.23M Buy
+25,190
New +$2.09M 0.51% 49

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Investment Advisory's ABBV Position: Q2 2026 in Review

Harbor Investment Advisory reduced its AbbVie (ABBV) stake by 0.34% in Q2 2026, selling an estimated $14.8K and leaving 19,981 shares worth $5.03M. The position accounts for 0.35% of the portfolio, ranked #60.

Harbor Investment Advisory first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.06M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbor Investment Advisory held 19,981 shares of AbbVie worth $5.03M as of Q2 2026.
  • Harbor Investment Advisory sold 69 AbbVie shares in Q2 2026, an estimated $14.8K.
  • AbbVie made up 0.35% of Harbor Investment Advisory's portfolio in Q2 2026, its #60 holding.
  • Harbor Investment Advisory first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's AbbVie position peaked at $5.06M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.